Posted inClinical Updates news
FDA Approves ArteraAI Prostate: The First AI-Driven Software Transforming Localized Prostate Cancer Management
ArteraAI Prostate, the first FDA-approved AI-driven multimodal software, offers personalized clinical decision support for localized prostate cancer, improving treatment precision and reducing overtreatment risks.



















